Osaic Holdings’s IGC Pharma IGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,031
Closed -$1.03K 7575
2024
Q4
$1.03K Buy
3,031
+2,106
+228% +$788 ﹤0.01% 6837
2024
Q3
$397 Buy
925
+125
+16% +$50 ﹤0.01% 7048
2024
Q2
$344 Hold
800
﹤0.01% 7079
2024
Q1
$320 Sell
800
-232
-22% -$72 ﹤0.01% 6897
2023
Q4
$288 Sell
1,032
-1,082
-51% -$335 ﹤0.01% 6976
2023
Q3
$758 Buy
2,114
+1,882
+811% +$673 ﹤0.01% 6905
2023
Q2
$72 Hold
232
﹤0.01% 7314
2023
Q1
$78 Hold
232
﹤0.01% 7353
2022
Q4
$0 Hold
232
﹤0.01% 7294
2022
Q3
$0 Hold
232
﹤0.01% 7369
2022
Q2
$0 Hold
232
﹤0.01% 7459
2022
Q1
$0 Hold
232
﹤0.01% 7346
2021
Q4
$0 Sell
232
-13,000
-98% -$17.4K ﹤0.01% 7462
2021
Q3
$20K Sell
13,232
-500
-4% -$808 ﹤0.01% 5769
2021
Q2
$23K Sell
13,732
-16
-0.1% -$24 ﹤0.01% 5569
2021
Q1
$25K Buy
13,748
+13,016
+1,778% +$23.6K ﹤0.01% 5337
2020
Q4
$1K Hold
732
﹤0.01% 6217
2020
Q3
$1K Hold
732
﹤0.01% 6013
2020
Q2
$0 Hold
732
﹤0.01% 6206
2020
Q1
$0 Buy
+732
New +$406 ﹤0.01% 6115

Other funds holding IGC

Osaic Holdings's IGC Position: Q1 2025 in Review

Osaic Holdings sold out of IGC Pharma (IGC) in Q1 2025, closing a stake of 3,031 shares — an estimated $1.03K sold.

Osaic Holdings first reported a position in IGC in Q1 2020 and held it in 20 quarters. The position peaked at $25K in Q1 2021. 25 funds tracked by Wall St. Rank hold IGC as of Q1 2025.

  • Osaic Holdings reported no remaining IGC Pharma position as of Q1 2025 after selling out during the quarter.
  • Osaic Holdings sold 3,031 IGC Pharma shares in Q1 2025, an estimated $1.03K.
  • Osaic Holdings first reported a position in IGC Pharma in Q1 2020 and held it in 20 quarters.
  • Osaic Holdings's IGC Pharma position peaked at $25K in Q1 2021.
  • 25 funds tracked by Wall St. Rank held IGC Pharma as of Q1 2025.

Based on Osaic Holdings's 13F filing for Q1 2025, filed 12 May 2025.